1. Home
  2. VNDA vs GWRS Comparison

VNDA vs GWRS Comparison

Compare VNDA & GWRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VNDA
  • GWRS
  • Stock Information
  • Founded
  • VNDA 2002
  • GWRS 2003
  • Country
  • VNDA United States
  • GWRS United States
  • Employees
  • VNDA N/A
  • GWRS N/A
  • Industry
  • VNDA Biotechnology: Pharmaceutical Preparations
  • GWRS Water Supply
  • Sector
  • VNDA Health Care
  • GWRS Utilities
  • Exchange
  • VNDA Nasdaq
  • GWRS Nasdaq
  • Market Cap
  • VNDA 237.9M
  • GWRS 270.6M
  • IPO Year
  • VNDA 2006
  • GWRS 2010
  • Fundamental
  • Price
  • VNDA $4.33
  • GWRS $10.17
  • Analyst Decision
  • VNDA Strong Buy
  • GWRS
  • Analyst Count
  • VNDA 2
  • GWRS 0
  • Target Price
  • VNDA $16.50
  • GWRS N/A
  • AVG Volume (30 Days)
  • VNDA 754.6K
  • GWRS 69.4K
  • Earning Date
  • VNDA 05-07-2025
  • GWRS 05-07-2025
  • Dividend Yield
  • VNDA N/A
  • GWRS 2.98%
  • EPS Growth
  • VNDA N/A
  • GWRS N/A
  • EPS
  • VNDA N/A
  • GWRS 0.24
  • Revenue
  • VNDA $198,772,000.00
  • GWRS $52,692,000.00
  • Revenue This Year
  • VNDA $14.36
  • GWRS $7.63
  • Revenue Next Year
  • VNDA $44.53
  • GWRS $5.58
  • P/E Ratio
  • VNDA N/A
  • GWRS $42.52
  • Revenue Growth
  • VNDA 3.18
  • GWRS N/A
  • 52 Week Low
  • VNDA $3.85
  • GWRS $9.37
  • 52 Week High
  • VNDA $6.75
  • GWRS $13.98
  • Technical
  • Relative Strength Index (RSI)
  • VNDA 43.42
  • GWRS 42.99
  • Support Level
  • VNDA $4.27
  • GWRS $10.04
  • Resistance Level
  • VNDA $4.46
  • GWRS $10.46
  • Average True Range (ATR)
  • VNDA 0.22
  • GWRS 0.40
  • MACD
  • VNDA 0.01
  • GWRS 0.05
  • Stochastic Oscillator
  • VNDA 54.55
  • GWRS 59.26

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

About GWRS Global Water Resources Inc.

Global Water Resources Inc operates as a water resources management company that owns, operates, and manages water, wastewater, and recycled water utilities in strategically located communities, principally in metropolitan Phoenix, Arizona. It operates within the State of Arizona.

Share on Social Networks: